Publications from external organizations that use EpiVax tools or methods.
Considerations for the rapid deployment of vaccines against H7N9 influenza. Chua BY, Brown LE, Jackson DC. University of Melborne. Expert Rev Vaccines. 2014 Jul 12
Development of Scoring Functions for Antibody Sequence Assessment and Optimization Daniel Seeliger, Silvio C. E. Tosatto, Editor. Boehringer Ingelheim Pharma PLoS One. 2013; 8(10) [Use of ISPRI tool to develop Humanized antibody concept].
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. Stuart L. Emanuel, et. al. Adnexus MAbs. 2011 [ISPRI prediction of immunogenicity]
Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein E. Koren, A.S. De Groot, V. Jawa, K.D. Beck, T. Boone, D. Rivera, L. Lid, D. Mytych, M. Kosce, D. Weeraratne, S. Swanson, W. Martin. Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]
Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria. Gámez A, Wang L, Sarkissian CN, Wendt D, Fitzpatrick P, Lemontt JF, Scriver CR, Stevens RC. Scripps Research Institute. Mol Genet Metab. 2007 Aug. [ISPRI prediction of immunogenicity]